These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1917132)

  • 1. Expression of integrin receptors on 45 clinical neuroblastoma specimens.
    Favrot MC; Combaret V; Goillot E; Lutz P; Frappaz D; Thiesse P; Thyss A; Dolbeau D; Bouffet E; Tabone E
    Int J Cancer; 1991 Sep; 49(3):347-55. PubMed ID: 1917132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of leucocyte adhesion molecules on 66 clinical neuroblastoma specimens.
    Favrot MC; Combaret V; Goillot E; Tabone E; Bouffet E; Dolbeau D; Bouvier R; Coze C; Michon J; Philip T
    Int J Cancer; 1991 Jun; 48(4):502-10. PubMed ID: 1710608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of integrin and CD44 adhesion molecules on neuroblastoma: the relation to tumor aggressiveness and embryonic neural-crest differentiation.
    Combaret V; Coll JL; Favrot MC
    Invasion Metastasis; 1994-1995; 14(1-6):156-63. PubMed ID: 7544774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitronectin expression in differentiating neuroblastic tumors: integrin alpha v beta 5 mediates vitronectin-dependent adhesion of retinoic-acid-differentiated neuroblastoma cells.
    Gladson CL; Dennis C; Rotolo TC; Kelly DR; Grammer JR
    Am J Pathol; 1997 May; 150(5):1631-46. PubMed ID: 9137089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The calcium-sensing receptor and parathyroid hormone-related protein are expressed in differentiated, favorable neuroblastic tumors.
    de Torres C; Beleta H; Díaz R; Toran N; Rodríguez E; Lavarino C; García I; Acosta S; Suñol M; Mora J
    Cancer; 2009 Jun; 115(12):2792-803. PubMed ID: 19350667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin expression in human neuroblastoma cells with or without N-myc amplification and in ectopic/orthotopic nude mouse tumors.
    Flickinger KS; Judware R; Lechner R; Carter WG; Culp LA
    Exp Cell Res; 1994 Jul; 213(1):156-63. PubMed ID: 8020586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of P-glycoprotein restricted to normal cells in neuroblastoma biopsies.
    Favrot M; Combaret V; Goillot E; Wagner JP; Bouffet E; Mazingue F; Thyss A; Bordigoni P; Delsol G; Bailly C
    Br J Cancer; 1991 Aug; 64(2):233-8. PubMed ID: 1679995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas.
    Suzuki T; Bogenmann E; Shimada H; Stram D; Seeger RC
    J Natl Cancer Inst; 1993 Mar; 85(5):377-84. PubMed ID: 8433391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.
    Krajewski S; Chatten J; Hanada M; Reed JC
    Lab Invest; 1995 Jan; 72(1):42-54. PubMed ID: 7837790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage-specific expression of integrin alphaVbeta3 in neuroblastic tumors.
    Gladson CL; Hancock S; Arnold MM; Faye-Petersen OM; Castleberry RP; Kelly DR
    Am J Pathol; 1996 May; 148(5):1423-34. PubMed ID: 8623914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas.
    Nakagawara A; Zaizen Y; Ikeda K; Suita S; Ohgami H; Nagahara N; Sera Y; Akiyama H; Kawakami K; Uchino J
    Cancer; 1991 Nov; 68(9):2037-44. PubMed ID: 1913552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of TRKA expression on neuroblastoma: comparison with N-MYC amplification and CD44 expression.
    Combaret V; Gross N; Lasset C; Balmas K; Bouvier R; Frappaz D; Beretta-Brognara C; Philip T; Favrot MC; Coll JL
    Br J Cancer; 1997; 75(8):1151-5. PubMed ID: 9099963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.
    Castle VP; Heidelberger KP; Bromberg J; Ou X; Dole M; Nuñez G
    Am J Pathol; 1993 Dec; 143(6):1543-50. PubMed ID: 8256847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis.
    Shimada H; Stram DO; Chatten J; Joshi VV; Hachitanda Y; Brodeur GM; Lukens JN; Matthay KK; Seeger RC
    J Natl Cancer Inst; 1995 Oct; 87(19):1470-6. PubMed ID: 7674334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inverse expressions of the N-myc oncogene and beta 1 integrin in human neuroblastoma: relationships to disease progression in a nude mouse model system.
    Judware R; Lechner R; Culp LA
    Clin Exp Metastasis; 1995 Mar; 13(2):123-33. PubMed ID: 7533687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of neuronal src mRNA as a favorable marker and inverse correlation to N-myc gene amplification in human neuroblastomas.
    Matsunaga T; Shirasawa H; Tanabe M; Ohnuma N; Kawamura K; Etoh T; Takahashi H; Simizu B
    Int J Cancer; 1994 Sep; 58(6):793-8. PubMed ID: 7523310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaplastic large cell neuroblastoma.
    Abramowsky CR; Katzenstein HM; Alvarado CS; Shehata BM
    Pediatr Dev Pathol; 2009; 12(1):1-5. PubMed ID: 18397155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
    Nakagawara A; Arima-Nakagawara M; Scavarda NJ; Azar CG; Cantor AB; Brodeur GM
    N Engl J Med; 1993 Mar; 328(12):847-54. PubMed ID: 8441429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying genes involved in regulating differentiation of neuroblastoma cells.
    Rudie Hovland A; Nahreini P; Andreatta CP; Edwards-Prasad J; Prasad KN
    J Neurosci Res; 2001 May; 64(3):302-10. PubMed ID: 11319775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas.
    Wang Q; Hii G; Shusterman S; Mosse Y; Winter CL; Guo C; Zhao H; Rappaport E; Hogarty MD; Maris JM
    Cancer Res; 2003 Apr; 63(7):1631-5. PubMed ID: 12670915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.